Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridization

Blood

Volumn 89, Issue 1, 1997, Pages 101-107

  Sungaran, R ^b   Markovic, B ^b   Chong, B H ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; THROMBOPOIETIN;

ARTICLE; BONE MARROW; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; KIDNEY; LIVER; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SPLEEN; THROMBOCYTOPOIESIS; TISSUE DISTRIBUTION;

EID: 0031035555     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.1.101.101_101_107     Document Type: Article

References (22)

1. Murphy MJ Jr: Megakaryocyte colony stimulating factor and thrombopoiesis. Hematol/Oncol Clin North Am 3:465, 1989
2. Kaushansky K: Thrombopoietin: The primary regulator of platelet production. Blood 86:419, 1995
3. de Sauvage F, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang W, Oles KJ, Hultgren B, Sloberg LA Jr, Goeddel DV, Eaton DL: Stimulation of megakaryopoiesis and thrombopoiesis by the c-mpl ligand. Nature 369:533, 1994
4. Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, Grant FJ, Heipel MD, Burkhead SK, Kramer JM, Bell LA, Sprecher CA, Blumberg H, Johnson R, Prunkard D, Ching AFT, Mathewes SL, Bailey MC, Forstrom JW, Buddle MM, Osborn SG, Evans SJ, Sheppard PO, Presnell SR, O'Hara PJ, Hagen FS, Roth GJ, Foster DC: Cloning and expression of murine thrombopietin cDNA and stimulation of platelet production in vivo. Nature 369:565, 1994
5. Wendung F, Maraskovsky E, Debili N, Florindo C, Teepe M, Titeux M, Methia N, Breton-Gorius J, Cosman D, Vainchenker W: c-mpl ligand is a humoral regulator of megakaryocytopotesis. Nature 369:571, 1994
6. Harker LA, Hunt P, Marzec UM, Kelly AB, Tomer A, Hanson SR, Stead RB: Dose response effects of pegylated human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet production and function in non-human primates. Blood 86:256a, 1995 (abstr, suppl 1)
7. Basser R, Clarke K, Green M, Cebon J, Marty J, Menchaca D, Tomita D, Begley G: Randomized, double-blind, placebo-controlled Phase 1 trial of pegylated megakaryocyte growth and development factor (PEG-rHuMGDF) administered to patients with advanced cancer before and after chemotherapy. Blood 86:257a, 1995 (abstr, suppl 1)
8. Hartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chang MS, Samal B, Nichol JL, Swift S, Johnson MJ, Hsu RY, Parker VP, Suggs S, Skrine JD, Merewether LA, Clogston C, Hsu E, Hokom MM, Hornkohl A, Choi E, Pangelinan M, Sun Y, Mar V, McNinch J, Simonet L, Jacobsen F, Xie C, Shutter J, Chute H, Basu R, Selander L, Trollinger D, Sieu L, Padilla D, Trail G, Elliot G, Izumi R, Covey T, Crouse J, Garcia A, Xu W, Del Castillo J, Biron J, Cole S, Hu MCT, Pacifici R, Ponting I, Saris C, Wen D, Yung YP, Lin H, Bosselman RA: Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor mpl. Cell 77:1117, 1994
9. Kuter DJ, Rosenberg RD: The reciprocal relationship of thrombopoietin (c-mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 85:2720, 1995
10. Stoffel R, Wiestner A, Skoda RC: Thrombopoietin in thrombocytopenic mice: Evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 87:567, 1996
11. McCarty JM, Sprugel KH, Fox NE, Sabath DE, Kaushansky K: Murine thrombopoietin mRNA levels are modulated by platelet count. Blood 86:3668, 1995
12. Foster CD, Sprecher CA, Grant FJ, Kramer JM, Kuijper JL, Holly RD, Whitmore TE, Heipel M.D, Bell LA, Ching AFT, McGrane V, Hart C, O'Hara PJ, Lok S: Human thrombopoietin: Gene structure, cDNA sequence, expression and chromosomal localisation. Proc Natl Acad Sci USA 91:13023, 1994
13. Markovic B, Kwan YL, Nicholls EM, Walsh C, Crouch RL: A sensitive method for the detection of poly-A tails of mRNA using a biotin labelled heteropolymer of dT:rA. J Pathol 167:369, 1992
14. Markovic B, Wu ZH, Chesterman CN, Chong BC: Quantitation of FcgRII mRNA in platelets and megakaryoblastic cell lines by a new method of in situ hybridization. J Immunol Methods 172:105, 1994
15. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol 215:403, 1990
16. Ballmaier M, Bogenberger J, Shutter J, Welcher A, Tidow N, Konig A, Wilken A, v Schweinitz D, Hadam M, Weite K: Analysis of expression of megakaryocyte growth and development factor mRNA in various human normal and malignant tissues. Blood 84:241a, 1994 (abstr, suppl 1)
17. Shimada Y, Kato T, Ogami K, Horie K, Kokunbo A, Kudo Y, Maeda E, Sohma Y, Akahori H, Kawamura K, Miyazaki H: Thrombopoietin (TPO) is produced by the liver. Blood 84:326a, 1994 (abstr, suppl 1)
18. Chang M, Suen Y, Meng G, Buzby J, Williams S, Shen V, Knoppel A, Fernandez G, Cairo MS: Regulation of TPO mRNA expression and protein production: TPO gene regulation appears post transcriptional, and endogenous levels are inversely correlated to megakaryocyte mass and circulating platelet count. Blood 86:368a, 1995 (abstr, suppl 1)
19. Nagahisa H, Nagata Y, Ohnuki T, Osada M, Abe T, Todokoro K: Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation. Blood 87:1309, 1996
20. Shivadasani RA, Rosenblatt MF, Zucker-Franklin D, Jackson CW, Hunt P, Saris CJM, Orkin SH: Transcription factor NF-E2 is required for platelet formation independant of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 81:695, 1995
21. Han ZC, Sensebe L, Abgrall JF, Briere J: Platelet factor 4 inhibits human megakaryocytopoiesis in vitro. Blood 75:1234, 1990
22. Emmons RVB, Shulman NR, Reid DM, Young NS, Meng YG, Lee WL, Cohen RL, Dunbar CE: Thrombocytopenic patients with aplastic anemia have high TPO levels whereas those with immune thrombocytopenia are much lower. Blood 86:372a, 1995 (abstr, suppl 1)